Status:
RECRUITING
A Fruit and Vegetable Prescription Program
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Diabetes Mellitus
Diabetes Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Dietary intake of fruits and vegetables (F\&V) is a cornerstone for the treatment of type 2 diabetes, however less than 16% of Hispanic adults consume the recommended number of servings each day. F\&V...
Detailed Description
Consuming a nutrient-dense diet, rich in fruits and vegetables (F\&Vs) is at the cornerstone of type 2 diabetes (T2DM) treatment. Yet, among Hispanic adults, only 16% meet the recommended minimum F\&V...
Eligibility Criteria
Inclusion
- Patient at Penn State Health St. Joe's Medical Center
- Diagnosis of Type 2 Diabetes Mellitus greater than or equal to six months
- A1c level is greater than or equal to 7% (53 mmol/mol)
- Low income defined as enrolled in Supplemental Nutrition Assistance Program (SNAP), is uninsured or have Medicaid, or identifying as food insecure based on USDA criteria.
- Ability to give a blood sample
- Willing to respond to contacts from study staff over the study period
- Willing and able to give informed consent
- Can read and write in English or Spanish
Exclusion
- Diagnosis of Type 2 Diabetes Mellitus less than six months
- Patients who have previously participated in the Veggie Rx program in the past year
- Patients who have attended any diabetes self-management education and support (DSME/S) sessions in the past year
- Women who are pregnant or who plan to become pregnant during the study period
- Any uncontrolled mental illness or substance abuse, or inpatient treatment for these in the past six months
- Any unstable or significant medical condition in the past 3 months (e.g. recent heart attack, stroke, DVT)
- A1c level is less than 7%
- Does not speak English or Spanish
- Inability to provide informed consent
- Unable to give a blood sample
Key Trial Info
Start Date :
July 26 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06107816
Start Date
July 26 2024
End Date
July 1 2027
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State Health St. Joseph Downtown Campus
Reading, Pennsylvania, United States, 19601